Group One Trading’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Group One Trading’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,862	Closed	-$133K	–	6065
2019 Q4	$134K	Buy	2,862 +2,562	+854%	+$113K	﹤0.01%	3456
2019 Q3	$7K	Hold	300	–	–	﹤0.01%	4703
2019 Q2	$9K	Sell	300 -1,200	-80%	-$27.5K	﹤0.01%	4472
2019 Q1	$34K	Buy	+1,500	New	+$32.2K	﹤0.01%	3779

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Group One Trading's RARX Position: Q1 2020 in Review

Group One Trading sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q1 2020, closing a stake of 2,862 shares — an estimated $133K sold.

Group One Trading first reported a position in RARX in Q1 2019 and held it in 4 quarters. The position peaked at $134K in Q4 2019. 144 funds tracked by Wall St. Rank hold RARX as of Q1 2020.

Group One Trading reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Group One Trading sold 2,862 Ra Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $133K.
Group One Trading first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 4 quarters.
Group One Trading's Ra Pharmaceuticals, Inc. Common Stock position peaked at $134K in Q4 2019.
144 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.